bluuebunny/crossref_metadata_2025_split huggingface dataset:
Expression of Peroxisome Proliferator-Activated Receptor Alpha (PPARα) in Non-Somatotroph Pituitary Tumours and the Effects of PPARα Agonists on MMQ Cells
Authors: Polidoro Michela , Rotondi Sandra , Morace Roberta , Rostomyan Liliya , Colapietro Alessandro , Arcella Antonietta , Ventura Luca , Angelucci Adriano , Giangaspero Felice , Esposito Vincenzo , Beckers Albert , Jaffrain-Rea Marie-Lise 
Published: July 2018

AbstractPeroxisome proliferator-activated receptor alpha (PPARα) has been involved in the regulation of somatotroph tumour cells and may be targeted by different drugs, some of them are in current clinical use. The aim of this study was to investigate the expression of PPARα in additional phenotypes of pituitary adenomas (PA), the relationship between PPARα and its potential molecular partner aryl hydrocarbon receptor interacting protein (AIP) in these tumours, and the effects of PPARα agonists on lactotroph cells. Seventy-five human PA – 57 non-functioning (NFPA) and 18 prolactinomas (PRL-PA) – were characterised for PPARα and AIP expression by real time RT-PCR and/or immunohistochemistry (IHC), and the effects of fenofibrate and WY 14 643 on MMQ cells were studied in vitro. PPARα was expressed in a majority of PA. PPARα immunostaining was observed in 93.7% PRL-PA vs. 60.6% NFPA (p=0.016), the opposite being found for AIP (83.3% in NFPA vs. 43.7% in PRL-PA, p=0.003). PPARα expression was unrelated to gonadotroph differentiation in NFPA, but positively correlated with tumour volume in PRL-PA. Both drugs significantly reduced MMQ cell growth at high concentrations (100–200 μM). At the same time, despite modest stimulating effects on PRL secretion were observed, these were overcome by the reduction in cell number. In conclusion, PPARα is commonly expressed by PRL-PA and NFPA, regardless of AIP, and may represent a new target of PPARα agonists.
Assessment of Needs for Counseling After Prenatal Diagnosis of Congenital Heart Disease – A Multidisciplinary Approach
Authors: Kovacevic Alexander , Simmelbauer Andreas , Starystach Sebastian , Elsässer Michael , Sohn Christof , Müller Andreas , Bär Stefan , Gorenflo Matthias 
Published: July 2018

Abstract
Background Congenital heart disease is the most common cause of major congenital anomalies. After prenatal diagnosis effective counseling is crucial. However, little research has been undertaken in determining the most effective techniques.
Objectives To develop a questionnaire suitable to assess parental needs for counseling.
Material and Methods A questionnaire was developed by pediatric cardiologists, maternal-fetal-medicine specialists and sociologists. Likert scaled and open-ended questions are combined with socio-demographical data. The questionnaire was prospectively pilot-tested on 17 parents. We present first analyses of n=41 parents.
Results Response rate was 89.5%. The dependent variable “effective counseling” was measured in 5 dimensions (transfer of medical information, trust in medical staff, transparency of treatment process, coping resources and perceived situational control). The questionnaire’s internal consistency is high (Cronbach’s alpha>0.7). First analyses show that 44.7% perceived counseling as successful. Transfer of medical information seems difficult (36.6% success rate). Trust in medical staff was high with 75%.
Conclusions This newly developed tool measures counseling success in five dimensions. A multidisciplinary approach is recommended as methodological expertise is essential for constructing adequate tests. Preliminary data indicate that transfer of medical information is not easily achieved. Further analyses are needed to identify factors that determine counseling success.
Stadiengerechte Therapie der akuten Divertikulitis anhand der neuen Klassifikation der Divertikelkrankheit
Authors: Lock Johan , Schneider Patrick , Lang Stefanie , Wagner Eyleen , Pelz Jörg , Reibetanz Joachim , Germer Christoph 
Published: July 2018

Zusammenfassung
Hintergrund In den vergangenen Jahren gab es einen deutlichen Wandel in den Therapieempfehlungen der akuten Divertikulitis. Die stadiengerechte Therapie orientiert sich an der neuen Klassifikation der Divertikelkrankheit aus der aktuellen Leitlinie.
Patienten und Methode Erfasst wurden alle Patienten, die in den Jahren 2010 bis 2014 wegen einer akuten Divertikulitis im Universitätsklinikum Würzburg behandelt wurden. Einschlusskriterium für die Auswertung war das Vorhandensein einer Computertomografie zur Stadieneinteilung.
Ergebnisse Gut die Hälfte der untersuchten Patienten (n = 135, 52,9%) hatte bei Aufnahme eine akute unkomplizierte Divertikulitis, 112 (43,2%) wiesen eine gedeckte Perforation (Mikroabszess n = 63, 24,3%; bzw. Makroabszess n = 49, 18,9%), 12 Patienten (4,6%) eine freie Perforation auf. Bei insgesamt 150 (57,9%) Patienten war es der 1. Schub einer Divertikulitis, eine gedeckte (66,1%) oder eine freie Perforation (75,0%) trat dabei überdurchschnittlich häufig als Erstmanifestation auf. Knapp zwei Drittel (66,4%, n = 168) der Patienten wurden im Verlauf sigmareseziert.
Diskussion und Schlussfolgerung Trotz des Trends hin zu einer konservativen Therapie der akuten Divertikulitis bleibt die (elektive) Sigmaresektion nach wie vor ein zentraler Bestandteil in der Therapie über alle Stadien hinweg. Die Indikationsstellung ist jedoch heutzutage deutlich differenzierter und erfordert neben der individuellen Klassifikation der Entzündungssituation auch Kenntnisse über die individuelle krankheitsspezifische Prognose in Bezug auf Rezidivwahrscheinlichkeit und Lebensqualität.
Innovation und Evaluation in der Chirurgie
Authors: Probst Pascal , Mihaljevic Andre L. , Neudecker Jens , Diener Markus K. 
Published: July 2018

ZusammenfassungInnovation und Evaluation werden in der Chirurgie häufig als Gegenspieler betrachtet. Vermeintlich hemme die Evaluation durch prospektive Studien die
Innovationskraft des einzelnen Chirurgen oder der Industrie. Dieser Artikel beleuchtet das Themengebiet der Evaluation durch Studien in der Chirurgie und zeigt
auf, inwiefern Evaluation hilft, Innovation zu fördern und dabei einen wichtigen Beitrag zur Verteilung der Ressourcen im Gesundheitswesen leistet. Nur im
Zusammenspiel zwischen Innovation und Evaluation kann sichergestellt werden, dass es nicht nur vorangeht, sondern auch die Richtung stimmt.
Delitpyrones: α-Pyrone Derivatives from a Freshwater Delitschia sp.
Authors: Rivera-Chávez José , El-Elimat Tamam , Gallagher Jacklyn , Graf Tyler , Fournier Jacques , Panigrahi Gati , Deep Gagan , Bunch Rick , Raja Huzefa , Oberlies Nicholas 
Published: July 2018

AbstractIn research focused on the discovery of new chemical diversity from freshwater fungi, a peak library was built and evaluated against a prostate cancer cell line, E006AA-hT, which was derived from an African American, as this population is disproportionately affected by prostate cancer. The chemical study of the bioactive sample accessioned as G858 (Delitschia sp.) led to the isolation of eight new α-pyrone derivatives (1 – 7, and 11), as well as the new 3S*,4S*-7-ethyl-4,8-dihydroxy-3,6-dimethoxy-3,4-dihydronaphthalen-1(2H)-one (15). In addition, the known compounds 5-(3-S-hydroxybutyl)-4-methoxy-6-methyl-2H-pyran-2-one (8), 5-(3-oxobutyl)-4-methoxy-6-methyl-2H-pyran-2-one (9), pyrenocine I (10), 5-butyl-6-(hydroxymethyl)-4-methoxy-2H-pyran-2-one (12), sporidesmin A (13), 6-ethyl-2,7-dimethoxyjuglone (14), artrichitin (16), and lipopeptide 15G256ε (17) were also obtained. The structures of the new compounds were elucidated using a set of spectroscopic (NMR) and spectrometric (HRMS) methods. The absolute configuration of the most abundant member of each subclass of compounds was assigned through a modified Mosherʼs ester method. For 15, the relative configuration was assigned based on analysis of 3
J values. Compounds 1, 2, 5 – 14, 16, and 17 were evaluated against the cancer cell line E006AA-hT under hypoxic conditions, where compound 13 inhibited cell proliferation at a concentration of 2.5 µM.
Increased Tissue Thromboplastin Activity in Monocytes of Patients with Meningococcal Infection: Related to an Unfavourable Prognosis
Authors: Østerud B , Flægstad T 
Published: July 2018

SummaryIn 16 patients, 13 with meningococcal infection and 3 suspected to have this infection, 8 patients were found to possess significant higher level of tissue thromboplastin activity of their monocytes isolated from the blood at the admission to the hospital than normal. Five of those 8 patients had an extremely high concentration, > 60-300 fold increase, and all these patients died. The exposed tissue thromboplastin activity on the surface of the endotoxin stimulated monocytes is probably the direct inducer of disseminated intravascular coagulation (DIC) in meningococcal infection.
Increased Urinary β-Thromboglobulin Excretion in Diabetes Assayed with a Modified RIA Kit-Technique
Authors: van Oost Bernard A , Veldhuyzen Bernard , Timmermans Ans P M , Sixma Jan J 
Published: July 2018

SummaryA modification of the commercial radioimmunoassay (RIA) kit adapting to the assay of β-thromboglobulin (β-TG) in the urine, is described. The urine was concentrated by dialysis against dry Sepharose G 200. l31I-albumin was used as marker. Experiments in which l25I-β-TG and 131I-albumin were added simultaneously showed a parallel recovery of both markers in the final sample. The sensitivity of the RIA was enhanced by incubation overnight of the urine sample with the antiserum. Increased urinary pTG values were found in 20 patients with diabetes mellitus as compared to 20 young healthy normals. Increased urinary β-TG values correlated with decreased creatinine clearance, but the difference between diabetics and normals was still observed when patients with a creatinine clearance of less than 100 ml/min were excluded. The urine βTG level was correlated with the presence of neovascularization within the diabetic group.
High Molecular Weight Forms of Antithrombin III Complexes in Blood
Authors: Marciniak E , Gora-Maslak G 
Published: July 2018

SummaryA double antibody competition radioimmunoassay was developed that allowed to detect specifically as little as 15 ng antithrombin III (AT III) per ml of the assayed material. In normal plasma examined by this assay, AT III concentration averaged 199 ± 21 μg/ml. Complexes of AT III with thrombin or factor X a crossreacted with free AT III in 87% and 95%, respectively. Molecular forms of AT III produced in plasma treated with coagulation enzymes, or in serum, were assessed by measuring immunoreactive AT III in fractions obtained by gel filtration chromatography on Sephadex G-200. AT III bound by thrombin in fibrinogen free-plasma ranged in molecular size from 160,000 to above 250,000. Similar aggregation occurred when monomeric complex of purified AT III and thrombin, of 90,000 Mr, was added to plasma. Presence of heparin intensified the degree of aggregation. In factor Xa-treated plasma AT III was converted into components with 160,000 Mr, or less. No complexes below 200,000 Mr were present in serum. They decreased in size to 160,000 Mr after affinity chromatography on heparin-Sepharose. These results indicated that blood represents a unique milieu conducive to aggregation of bound AT III. It appears, however, that AT III complexes present in blood may not only aggregate, but also associate with other serum proteins through unstable binding most likely caused by the enzyme component of the complex.
Fibrin Network Structure: Modification by Platelets
Authors: Dhall T Z , Shah G A , Ferguson I A , Dhall D P 
Published: July 2018

SummaryPlatelets play a fundamental role in haemostasis and thrombosis. They are known to undergo characteristic changes including release of subcellular material during clotting. The effect of subcellular platelet material on fibrin network structure, however, has not previously been investigated. Using opacity ratio, syneresis, permeation and electron microscopy it was found that subcellular platelet material extracted into NaCl is able to influence fibrin network structure of clots made from purified fibrinogen as well as platelet-poor plasma. Such clots had higher opacity ratio, reduced syneresis and lower permeability than control clots. Further, the responsible platelet material is heat labile and is released from the platelets during their aggregation with several common aggregating agents. Morphometric analysis of transmission electron micrographs has shown that fibrin fibres in plasma clots made in the presence of platelet subcellular material are thinner than those in control clots. In addition, plasma clots made in the presence of platelet extract had a higher resistance to fibrinolytic digestion than control clots. Thus, platelets play a hitherto undescribed role in regulating fibrin network structure.
The Basis for the Increase in Factor VIII Procoagulant Activity During Exercise
Authors: Kopitsky Robert G , Switzer Mary Ellen P , Williams R Sanders , McKee Patrick A 
Published: July 2018

SummaryWe studied the effect of acute exercise on the ability of thrombin to activate plasma factor VIII (FVIII) activity in 20 healthy males. The subject showed an average exercise-related increase in FVIII activity of 54.5±8.2% over pre-exercise FVIII activity (p<0.001). When exposed to the same concentration of thrombin, post-exercise FVIII activity showed greater enhancement than pre-exercise FVIII activity: 157.1±12.8% increase in activity versus 117.3±9.9%, respectively (p<0.01). The degree of the potentiated thrombin effect in post-exercise samples relative to pre-exercise samples was linearly correlated with the degree of the exercise-related increase in FVIII activity. Taken together with our previous observations that the extent of thrombin enhancement of FVIII activity varies inversely with the mole ratio of FVIII/von Willebrand factor subunits to thrombin, these findings imply that release of FVIII does not occur during exercise, and that the exercise-related increase in FVIII activity results primarily, if not completely, from activation of already circulating but inactive FVIII.
Heparin Counteracts the Antiaggregating Effect of Prostacyclin by Potentiating Platelet Aggregation
Authors: Bertelé Vittorio , Roncaglioni Maria Carla , Donati Maria Benedetta , Gaetano Giovanni de 
Published: July 2018

SummaryIt has recently been reported that heparin neutralizes the inhibitory effect of prostacyclin (PGI2) on human platelet aggregation. The mechanism of this interaction has not yet been unequivocally established. We present here evidence that heparin (Liquemin Roche) does not react directly with PGI2 but counteracts its inhibitory effect by potentiating platelet aggregation. In the absence of heparin, PGI2 was a less effective inhibitor of platelet aggregation induced by the combination of ADP and serotonin than by ADP alone. Moreover, the inhibitory effect of PGI2 was similarly reduced when increasing the concentrations of ADP (in the absence of heparin). The lack of a specific interaction between heparin and PGI2 is supported by the observation that, in the presence of heparin, other prostaglandins such as PGD2 and PGE1, and a non-prostanoid compound such as adenosine also appeared to lose their inhibitory potency. It is concluded that heparin opposes platelet aggregation inhibitory effect of PGI2 by enhancement of platelet aggregation.
Covalent Complexes Between Low Molecular Weight Heparin Fragments and Antithrombin III – Inhibition Kinetics and Turnover Parameters
Authors: Hoylaerts M , Holmer E , Mol M de , Collen D 
Published: July 2018

SummaryTwo high affinity heparin fragments (A/r 4,300 and M, 3,200) were covalently coupled to antithrombin III (J. Biol. Chem. 1982; 257: 3401-3408) with an apparent 1:1 stoichiometry and a 30-35% yield.The purified covalent complexes inhibited factor Xa with second order rate constants very similar to those obtained for antithrombin III saturated with these heparin fragments and to that obtained for the covalent complex between antithrombin III and native high affinity heparin.The disappearance rates from plasma in rabbits of both low molecular weight heparin fragments and their complexes could adequately be represented by two-compartment mammillary models. The plasma half-life (t'/j) of both low Afr-heparin fragments was approximately 2.4 hr. Covalent coupling of the fragments to antithrombin III increased this half-life about 3.5 fold (t1/2 ≃ 7.7 hr), approaching that of free antithrombin III (t1/2 ≃ 11 ± 0.4 hr) and resulting in a 30fold longer life time of factor Xa inhibitory activity in plasma as compared to that of free intact heparin (t1/2 ≃ 0.25 ± 0.04 hr).
A New Dysfibrinogenemia: Fibrinogen Oslo IV
Authors: Stormorken H , Brosstad F , Seim H 
Published: July 2018

SummaryA family with dysfibrinogenemia is described. The abnormal fibrinogen occurred in three successive generations indicating a dominant hereditary pattern. Thrombin and reptilase times were about twice the normal value. This was shown to be caused by a polymerization defect, fibrinopeptide release being normal. Platelet aggregation was undisturbed, indicating normal platelet-fibrinogen binding. The bleeding time was normal and there was no bleeding tendency. However, an obscure recurrent pulmonary ailment may, or may not, be related to the dysfibrinogenemia. The abnormal fibrinogen was tentatively termed Oslo IV.
Effects of Dipyrone on Prostaglandin Production by Human Platelets and Cultured Bovine Aortic Endothelial Cells
Authors: Eldor A , Polliack G , Vlodavsky I , Levy M 
Published: July 2018

SummaryDipyrone and its metabolites 4-methylaminoantipyrine, 4-aminoantipyrine, 4-acetylaminoantipyrine and 4-formylaminoan- tipyrine inhibited the formation of thromboxane A2 (TXA2) during in vitro platelet aggregation induced by ADP, epinephrine, collagen, ionophore A23187 and arachidonic acid. Inhibition occurred after a short incubation (30–40 sec) and depended on the concentration of the drug or its metabolites and the aggregating agents. The minimal inhibitory concentration of dipyrone needed to completely block aggregation varied between individual donors, and related directly to the inherent capacity of their platelets to synthesize TXA2.Incubation of dipyrone with cultured bovine aortic endothelial cells resulted in a time and dose dependent inhibition of the release of prostacyclin (PGI2) into the culture medium. However, inhibition was abolished when the drug was removed from the culture, or when the cells were stimulated to produce PGI2 with either arachidonic acid or ionophore A23187.These results indicate that dipyrone exerts its inhibitory effect on prostaglandins synthesis by platelets or endothelial cells through a competitive inhibition of the cyclooxygenase system.
Pre- and Postoperative Levels of Antithrombin III with Special Reference to Thromboembolism After Total Hip Replacement
Authors: Fredin H , Nilsson B , Rosberg B , Tengborn L 
Published: July 2018

SummaryA prospective study of antithrombin HI, determined by electroimmunochemical assay or an amidolytical method, was carried out with special reference to thromboembolism after total hip replacement. Two hundred and seven patients were randomly allocated to thromboembolic prophylaxis with dextran 70 or low dose heparin combined with dihydroergotamine. Deep vein thrombosis determined by phlebography of the operated leg or pulmonary embolism diagnosed with perfusion/ventilation scintigraphy developed in 51% of the total material and did not differ significantly between the two groups of prophylaxis or between patients with a preoperative At III below normal and those with a normal value. The correlation between the two assay methods for At HI was 0.61. An initial, postoperative decrease in At III was noted with a parallel fall in hematocrit and fibrinogen, later followed by an increase of the plasma proteins. It is concluded that the immediate postoperative decrease of At III is mostly due to hemodilution.
Factors Influencing the Deaggregation of Human and Rabbit Platelets
Authors: Kinlough-Rathbone R L , Mustard J F , Perry D W , Dejana E , Cazenave J-P , Packham M A , Harfenist E J 
Published: July 2018

SummaryThe mechanisms involved in platelet deaggregation are unclear. Washed platelets from rabbits or humans aggregated by ADP can be deaggregated by EDTA or PGI2 if the release reaction has not occurred; during deaggregation 125I-fibrinogen dissociates from the platelets. Human platelets suspended in a medium without calcium undergo the release reaction during ADP-induced aggregation; EDTA, PGE, or PGI2 do not deaggregate these platelets although EDTA displaces much of the 125I-fibrinogen that associates with them during aggregation. Rabbit platelets aggregated by low concentrations of releaseinducing stimuli (sodium arachidonate, collagen or thrombin) can be deaggregated by EDTA, PGI2 or PGE1 and 125I-fibrinogen dissociates from them; with high concentrations of collagen or thrombin, deaggregation and dissociation of l25I-fibrinogen is slower. Human platelets that have undergone the release reaction in response to thrombin, collagen or a combination of sodium arachidonate and ADP are not readily deaggregated by EDTA or PGE1. Since aggregation and fibrinogen binding involving the glycoprotein IIb/IIIa complex are readily reversed by EDTA, and since Ca2+ is required for thrombospondin binding to activated platelets, there may be a third type of platelet-platelet adherence that is not disrupted by EDTA; this type of binding plays a greater role with human than with rabbit platelets.
Hemarthroses and Warfarin: Joint Destruction with Anticoagulation
Authors: Andes W Abe , Edmunds J Ollie 
Published: July 2018

SummaryA 56 year old man was seen because of recurrent right shoulder hemarthroses and a superior vena caval syndrome. Intermittent symptoms had occurred for six years and resulted in marked destructive changes in the right shoulder. Arthroscopy added pathological evidence of this unusual mechanism of arthropathy. Patients on anticoagulants deserve close attention to symptoms of occult bleeding.
Lipid Peroxidation and Experimental Disseminated Intravascular Coagulation in Rats Induced by Endotoxin
Authors: Yoshikawa T , Murakami M , Furukawa Y , Kato H , Takemura S , Kondo M 
Published: July 2018

SummaryThe experimental model of disseminated intravascular coagulation (DIC) in rats induced by a 4 hr sustained infusion of 100 mg/kg endotoxin was used to study the relationship between lipid peroxidation and DIC. Serum thiobarbituric acid (TBA) reactive substances, important and damaging products of lipid peroxidation, increased gradually during the infusion of endotoxin. The levels of TBA reactants in serum, abdominal aortic wall and ileum mucosa were significantly increased in rats infused with 100 mg/kg of endotoxin for 4 hr, as compared with the control rats continuously given 11.4 ml of physiological saline for 4 hr. However, the levels in liver and kidney tissues, and in gastric, jejunum and colon mucosa did not increase significantly.